Selectively frequent expression of CXCR5 enhances resistance to apoptosis in CD8(+)CD34(+) T cells from patients with T-cell-lineage acute lymphocytic leukemia. [electronic resource]
Producer: 20050215Description: 573-84 p. digitalISSN:- 0950-9232
- Adaptor Proteins, Signal Transducing -- genetics
- Antigens, CD34 -- metabolism
- Apoptosis -- drug effects
- CD8-Positive T-Lymphocytes -- drug effects
- Cell Adhesion -- drug effects
- Cell Line
- Cell Lineage -- drug effects
- Chemokine CXCL13
- Chemokines, CXC -- metabolism
- Chemotaxis -- drug effects
- Humans
- Inhibitor of Apoptosis Proteins
- Neoplasm Proteins -- genetics
- Nuclear Proteins -- genetics
- Precursor Cell Lymphoblastic Leukemia-Lymphoma -- genetics
- Receptors, CXCR5
- Receptors, Chemokine -- metabolism
- Receptors, Cytokine -- genetics
- Tumor Necrosis Factor-alpha -- pharmacology
- Up-Regulation -- genetics
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Retracted Publication
There are no comments on this title.
Log in to your account to post a comment.